Teladoc(TDOC) - 2025 Q4 - Annual Report

Table of Contents x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2025 or Washington, D.C. 20549 _______________________________________________ Form 10-K ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 _______________________________________________ TELADOC HEALTH, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION 155 E 44t ...